CBX1 Indicates Poor Outcomes and Exerts Oncogenic Activity in Hepatocellular Carcinoma (Q90381380)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031230%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

title

CBX1 Indicates Poor Outcomes and Exerts Oncogenic Activity in Hepatocellular Carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031230%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

main subject

hepatocellular carcinoma

1 reference

Yu-Feng Yang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031230%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Ying-Hua Pan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031230%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Qiu-Hong Tian

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031230%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Dan-Chun Wu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031230%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Shu-Guang Su

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031230%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

publication date

19 July 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031230%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

published in

Translational Oncology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031230%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031230%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031230%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

page(s)

1110-1118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031230%20AND%20SRC:MED&resulttype=core&format=json

Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial

13 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANON.2018.07.002

New partners for HP1 in transcriptional gene silencing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANON.2018.07.002

The HP1 protein family: getting a grip on chromatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANON.2018.07.002

Structure of the HP1 chromodomain bound to histone H3 methylated at lysine 9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANON.2018.07.002

Hepatic ontogeny and tissue distribution of mRNAs of epigenetic modifiers in mice using RNA-sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANON.2018.07.002

Heterochromatin Protein 1β (HP1β) has distinct functions and distinct nuclear distribution in pluripotent versus differentiated cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANON.2018.07.002

HP1 is involved in regulating the global impact of DNA methylation on alternative splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANON.2018.07.002

HP1-beta mobilization promotes chromatin changes that initiate the DNA damage response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANON.2018.07.002

A conformational switch in HP1 releases auto-inhibition to drive heterochromatin assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANON.2018.07.002

Hepatoma-derived growth factor-related protein 2 promotes DNA repair by homologous recombination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANON.2018.07.002

Prognostic values of distinct CBX family members in breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANON.2018.07.002

HP1γ expression is elevated in prostate cancer and is superior to Gleason score as a predictor of biochemical recurrence after radical prostatectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANON.2018.07.002

Analysis of HP1α regulation in human breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANON.2018.07.002

Heterochromatin protein HP1γ promotes colorectal cancer progression and is regulated by miR-30a.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANON.2018.07.002

CBX3 promotes tumor proliferation by regulating G1/S phase via p21 downregulation and associates with poor prognosis in tongue squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANON.2018.07.002

The heterochromatin protein 1 family is regulated in prostate development and cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANON.2018.07.002

Heterochromatin protein 1α mediates development and aggressiveness of neuroendocrine prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANON.2018.07.002

Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANON.2018.07.002

Heterochromatin protein 1 expression is reduced in human thyroid malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANON.2018.07.002

Propofol inhibits hepatocellular carcinoma growth and invasion through the HMGA2-mediated Wnt/β-catenin pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANON.2018.07.002

WNT10B/β-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANON.2018.07.002

Mammalian HP1 Isoforms Have Specific Roles in Heterochromatin Structure and Organization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANON.2018.07.002

The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANON.2018.07.002

Identification of ChIP-seq mapped targets of HP1β due to bombesin/GRP receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANON.2018.07.002

The human organic anion transporting polypeptide 8 (SLCO1B3) gene is transcriptionally repressed by hepatocyte nuclear factor 3beta in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANON.2018.07.002

HP1β suppresses metastasis of human cancer cells by decreasing the expression and activation of MMP2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANON.2018.07.002

Global cancer statistics, 2012

7 January 2021

1 reference

12 December 2020

HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy

1 reference

12 December 2020

Cancer statistics in China, 2015.

1 reference

12 December 2020

CBX3/heterochromatin protein 1 gamma is significantly upregulated in patients with non-small cell lung cancer.

1 reference

12 December 2020

10.1016/J.TRANON.2018.07.002

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031230%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031230%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

PubMed publication ID

30031230

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031230%20AND%20SRC:MED&resulttype=core&format=json